LEXAPRO

This brand name is authorized in Australia, Brazil, Ecuador, Hong Kong, Ireland, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, United States

Active ingredients

The drug LEXAPRO contains one active pharmaceutical ingredient (API):

1 Escitalopram UNII 5U85DBW7LO - ESCITALOPRAM OXALATE

Escitalopram is a selective inhibitor of serotonin (5-HT) re-uptake with high affinity for the primary binding site. It also binds to an allosteric site on the serotonin transporter, with a 1000 fold lower affinity. Read about Escitalopram

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LEXAPRO Tablet / Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB10	Escitalopram	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10181W, 8700X, 8701Y, 9432K, 9433L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 524200302115317, 524200306110311, 524200307133313, 524200309111317, 524200311114311, 524217060003501, 524218030003603, 524218030003703, 524218030003803, 524220020004307
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.224-06-03, 25.225-06-03, 25.226-06-03, 25.227-06-03
Country: HK	Department of Health Drug Office	Identifier(s): 50995, 50996, 50997, 50998
Country: IE	Health Products Regulatory Authority	Identifier(s): 28574, 31216, 31317, 32348, 38752, 45870, 45891, 45922, 45923, 45924
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179054F1022, 1179054F2029
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 282M2002
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 74969, 74977, 85081, 87998
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11034, 11036
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100182660, 100290615, 100380436, 100396621, 100419670, 100461655
Country: SG	Health Sciences Authority	Identifier(s): 12362P, 12363P, 12364P, 12365P
Country: US	FDA, National Drug Code	Identifier(s): 0456-2005, 0456-2010, 0456-2020, 55289-768, 55289-828, 63629-2981